Cited by 276Pain Mechanisms and TreatmentsCannabis and Cannabinoid ResearchIon Channels and Receptors

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Staton, Penny C., Hatcher, Jon P., Walker, Deborah J., Morrison, Alastair D., Shapland, Ellen M., Hughes, Jane P., Chong, Elizabeth, Mander, Palwinder K., Green, Paula J., Billinton, Andy, Fulleylove, Michael, Lancaster, Hilary C., Smith, Jason C., Bailey, Leigh T., Wise, Alan, Brown, Andrew J., Richardson, Jill C., Chessell, Iain P.·2008·Pain

DOI 10.1016/j.pain.2008.04.006

Open this paper in CoChat — free account

Abstract

It has been postulated that the G protein-coupled receptor, GPR55, is a third cannabinoid receptor. Given that the ligands at the CB(1) and CB(2) receptors are effective analgesic and anti-inflammatory agents, the role of GPR55 in hyperalgesia associated with inflammatory and neuropathic pain has been investigated. As there are no well-validated GPR55 tool compounds, a GPR55 knockout (GPR55(-/-)) mouse line was generated and fully backcrossed onto the C57BL/6 strain. General phenotypic analysis of GPR55(-/-) mice revealed no obvious primary differences, compared with wild-type (GPR55(+/+)) littermates. GPR55(-/-) mice were then tested in the models of adjuvant-induced inflammation and partial nerve ligation. Following intraplantar administration of Freund's complete adjuvant (FCA), inflammatory mechanical hyperalgesia was completely absent in GPR55(-/-) mice up to 14 days post-injection. Cytokine profiling experiments showed that at 14 days post-FCA injection there were increased levels of IL-4, IL-10, IFN gamma and GM-CSF in paws from the FCA-injected GPR55(-/-) mice when compared with the FCA-injected GPR55(+/+) mice. This suggests that GPR55 signalling can influence the regulation of certain cytokines and this may contribute to the lack of inflammatory mechanical hyperalgesia in the GPR55(-/-) mice. In the model of neuropathic hypersensitivity, GPR55(-/-) mice also failed to develop mechanical hyperalgesia up to 28 days post-ligation. These data clearly suggest that the manipulation of GPR55 may have therapeutic potential in the treatment of both inflammatory and neuropathic pain.

Integrity signals

Registry

Crossref · 10.1016/j.pain.2008.04.006

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
Seltzer, Z., Dubner, R., & Shir, Y. (1990) · Pain · doi:10.1016/0304-3959(90)91074-s · Cited by 1,847
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
A method for measurement of analgesic activity on inflamed tissue.
Randall, L. O., & Selitto, J. J. (1957) · PubMed · Cited by 1,568
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,526
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 732

Show all 49 references

Sorted by citations

Items 101–200 of 276

The cannabinoid WIN 55,212‐2‐mediated protection of dentate gyrus granule cells is driven by CB1receptors and modulated by TRPA1 and Cav2.2 channels
Koch, M., Kreutz, S., Böttger, C., Grabiec, U., Ghadban, C., Korf, H., & Dehghani, F. (2010) · Hippocampus · doi:10.1002/hipo.20772 · Cited by 45
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
Sisay, S., Pryce, G., Jackson, S. J., Tanner, C., Ross, R. A., Michael, G. J., Selwood, D. L., Giovannoni, G., & Baker, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076907 · Cited by 44
A potential role for GPR55 in the regulation of energy homeostasis
Simcocks, A. C., O’Keefe, L., Jenkin, K. A., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.005 · Cited by 42
Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
McKillop, A. M., Moran, B. M., Abdel‐Wahab, Y. H. A., Gormley, N., & Flatt, P. R. (2016) · Diabetologia · doi:10.1007/s00125-016-4108-z · Cited by 43
GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Gasperi, V., Dainese, E., Oddi, S., Sabatucci, A., & Maccarrone, M. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130108 · Cited by 41
Differential Activation of Cultured Neonatal Cardiomyocytes by Plasmalemmal Versus Intracellular G Protein-coupled Receptor 55
Yu, J. E., Deliu, E., Zhang, X.-Q., Hoffman, N. E., Carter, R. L., Grisanti, L. A., Brailoiu, G. C., Madesh, M., Cheung, J. Y., Force, T. L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.456178 · Cited by 40
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
DeMorrow, S., & Leyva-Illades (2013) · Cancer Management and Research · doi:10.2147/cmar.s35175 · Cited by 38
Cannabinoid CB2 Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1 Mechanism that is Independent of CB2 Receptors in Mice
Li, A.-L., Carey, L. M., Mackie, K., & Hohmann, A. G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241901 · Cited by 39
Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
Thompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 39
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
Pryce, G., & Baker, D. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661310 · Cited by 39
Cannabidiol and Neurodevelopmental Disorders in Children
Cheung, K. A. K., Mitchell, M. D., & Heussler, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643442 · Cited by 39
Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain
Munawar, N., Oriowo, M. A., & Masocha, W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00136 · Cited by 36
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice
Carey, L. M., Gutierrez, T., Deng, L., Lee, W.-H., Mackie, K., & Hohmann, A. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01062-2 · Cited by 35
Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor 55
Balenga, N. A. B., Henstridge, C. M., Kargl, J., & Waldhoer, M. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00004-x · Cited by 39
Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37
Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
Ruban, E., Ferro, R., Arifin, S. A., & Falasca, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140151 · Cited by 36
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints
Krustev, E., Reid, A. R., & McDougall, J. J. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0437-9 · Cited by 37
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
Zhou, J., Burkovskiy, I., Yang, H.-W., Sardinha, J., & Lehmann, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00264 · Cited by 37
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability
Giuffrida, A., & McMahon, L. R. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.004 · Cited by 40
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation
Bjursell, M., Ryberg, E., Wu, T., Greasley, P. J., Bohlooly‐Y, M., & Hjorth, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167965 · Cited by 32
GPR55 in the brain and chronic neuropathic pain
Armin, S., Muenster, S., Abood, M. E., & Benamar, K. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113248 · Cited by 31
A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55
Elbegdorj, O., Westkaemper, R. B., & Zhang, Y. (2012) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2012.10.005 · Cited by 34
The role of orphan G protein-coupled receptors in the modulation of pain: A review
Nourbakhsh, F., Atabaki, R., & Roohbakhsh, A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.028 · Cited by 31
A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse G-protein signalling pathways in sensory nerves in vivo
Gangadharan, V., Selvaraj, D., Kurejová, M., Njoo, C., Gritsch, S., Škoricová, D., Horstmann, H., Offermanns, S., Brown, A. J., Kuner, T., et al. (2013) · Pain · doi:10.1016/j.pain.2013.08.019 · Cited by 32
The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol Lipase
Inloes, J. M., Jing, H., & Cravatt, B. F. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00810 · Cited by 30
Effects of a Novel GPR55 Antagonist on the Arachidonic Acid Cascade in LPS-Activated Primary Microglial Cells
Saliba, S. W., Gläser, F., Deckers, A., Keil, A., Hurrle, T., Apweiler, M., Ferver, F., Volz, N., Endres, D., Bräse, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052503 · Cited by 30
Effects of intra‐basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear
Roche, M., Johnston, P., Mhuircheartaigh, O. N., Olango, W. M., Mackie, K., & Finn, D. P. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.08.009 · Cited by 29
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
Iozzo, M., Sgrignani, G., Comito, G., Chiarugi, P., & Giannoni, E. (2021) · Cells · doi:10.3390/cells10123396 · Cited by 29
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain
Małek, N., Kostrzewa, M., Makuch, W., Pajak, A., Kucharczyk, M. W., Piscitelli, F., Przewłocka, B., Marzo, V. D., & Starowicz, K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.012 · Cited by 28
Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor
Lingerfelt, M. A., Zhao, P., Sharir, H., Hurst, D. P., Reggio, P. H., & Abood, M. E. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01013 · Cited by 28
Druggable Lysophospholipid Signaling Pathways
Yanagida, K., & Valentine, W. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50621-6_7 · Cited by 26
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Pellesi, L., Ashina, M., & Martelletti, P. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2317778 · Cited by 27
Screening for Selective Ligands for GPR55 - Antagonists
Heynen‐Genel, S., Dahl, R. S., Shi, S., Milan, L. B., Hariharan, S., Sergienko, E. A., Hedrick, M., Dad, S., Stonich, D., Su, Y., et al. (2011) · Europe PMC (PubMed Central) · Cited by 27
Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors
Imbernón, M., Whyte, L. S., Díaz–Arteaga, A., Russell, W. R., Moreno‐Castellanos, N., Vazquez, M. J., González, C. R., Díaz‐Ruiz, A., López, M., Malagón, M. M., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.011 · Cited by 27
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
Wróbel, A., Serefko, A., Szopa, A., Ulrich, D., Poleszak, E., & Rechberger, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01002 · Cited by 26
Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors
Jurga, M., Jurga, A., Jurga, K., Kaźmierczak, B., Kuśmierczyk, K., & Chabowski, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011258 · Cited by 30
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24
GPR55: Metabolic Help or Hindrance?
Henstridge, C. M., Brown, A. J., & Waldhoer, M. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.012 · Cited by 24
The GPCR‐associated sorting protein 1 regulates ligand‐induced down‐regulation of GPR55
Kargl, J., Balenga, N. A. B., Platzer, W., Martini, L., Whistler, J. L., & Waldhoer, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01562.x · Cited by 25
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Shen, S., Wu, C., Yang, Z., Wang, K., Shao, Z., & Yan, W. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01472-9 · Cited by 23
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55
Kotsikorou, E., Lynch, D. L., Abood, M. E., & Reggio, P. H. (2010) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2010.12.003 · Cited by 25
The Expression of the Endocannabinoid Receptors CB2 and GPR55 is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice
Vera, D. M., Zhao, H., Bereczki, E., Rosell‐Valle, C., Shimozawa, M., Chen, G., de Fonseca, F. R., Nilsson, P., & Tambaro, S. (2023) · Biology · doi:10.3390/biology12060805 · Cited by 24
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain
Breen, C., Brownjohn, P. W., & Ashton, J. C. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.039 · Cited by 22
Behavioral Neurobiology of the Endocannabinoid System
Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 28
New intercellular lipid mediators and their GPCRs: An update
Im, D. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.01.002 · Cited by 22
Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review
Schouten, M., Dalle, S., & Koppo, K. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0220 · Cited by 22
What is the natural ligand of GPR55?
Okuno, T., & Yokomizo, T. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr022 · Cited by 21
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists
Yrjölä, S., Parkkari, T., Navia‐Paldanius, D., Laitinen, T., Kaczor, A. A., Kokkola, T., Mensah, F. A., Savinainen, J. R., Laitinen, J. T., Poso, A., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.050 · Cited by 21
Cellular distribution of cannabinoid‐related receptors TRPV1, PPAR‐gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia
Galiazzo, G., Silva, M. D., Giancola, F., Rinnovati, R., Peli, A., & Chiocchetti, R. (2021) · Equine Veterinary Journal · doi:10.1111/evj.13499 · Cited by 20
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief
Wilkerson, J. L., & Milligan, E. D. (2011) · ISRN Anesthesiology · doi:10.5402/2011/593894 · Cited by 20
Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55
Claff, T., Ebenhoch, R., Kley, J. T., Magarkar, A., Nar, H., & Weichert, D. (2025) · Nature Communications · doi:10.1038/s41467-025-57204-y · Cited by 18
Neurophysiology of Arthritis Pain
McDougall, J. J., & Linton, P. (2012) · Current Pain and Headache Reports · doi:10.1007/s11916-012-0300-0 · Cited by 20
Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal development
Kwok, C. H. T., Devonshire, I. M., Imraish, A., Greenspon, C. M., Lockwood, S., Fielden, C., Cooper, A. H., Woodhams, S. G., Sarmad, S., Ortori, C. A., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001027 · Cited by 18
The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases
Zhao, M., Wang, Z., Yang, M., Ding, Y. P., Zhao, M., Wu, H., Zhang, Y., & Lu, Q. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08829-y · Cited by 18
Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review
Naik, H., & Trojian, T. H. (2021) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000858 · Cited by 19
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology
Morales, P., Whyte, L. S., Chicharro, R., Gómez‐Cañas, M., Pazos, M. R., Goya, P., Irving, A. J., Fernández‐Ruíz, J., Ross, R. A., & Jagerovic, N. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01331 · Cited by 17
Design, synthesis and biological evaluation of GPR55 agonists
Fakhouri, L. I., Cook, C. D., Al‐Huniti, M. H., Console‐Bram, L., Hurst, D. P., Spano, M. B., Nasrallah, D. J., Caron, M. G., Barak, L. S., Reggio, P. H., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.016 · Cited by 18
The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
Nabata, K. J., Tse, E. K., Nightingale, T. E., Lee, A. H. X., Eng, J. J., Querée, M., Walter, M., & Krassioukov, A. V. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200420085712 · Cited by 18
Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
Narouze, S. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-102114 · Cited by 18
The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain
Zhang, M., Wang, T., Meng, F., Jiang, M., Wu, S., & Xu, H. (2024) · iScience · doi:10.1016/j.isci.2024.111409 · Cited by 17
Identification of human glycerophosphodiesterase 3 as an ecto phospholipase C that converts the G protein-coupled receptor 55 agonist lysophosphatidylinositol to bioactive monoacylglycerols in cultured mammalian cells
Tsutsumi, T., Matsuda, R., Morito, K., Kawabata, K., Yokota, M., Nikawadori, M., Inoue-Fujiwara, M., Kawashima, S., Hidaka, M., Yamamoto, T., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158761 · Cited by 17
Antinociceptive Effects of the GPR55 Antagonist CID16020046 Injected into the Rat Anterior Cingulate Cortex
Okine, B. N., Laughlin, G. M., Gaspar, J. C., Harhen, B., Roche, M., & Finn, D. P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.013 · Cited by 16
Preference for Glucose over Inositol Headgroup during Lysolipid Activation of G Protein-Coupled Receptor 55
Guy, A. T., Kano, K., Ohyama, J., Kamiguchi, H., Hirabayashi, Y., Ito, Y., Matsuo, I., & Greimel, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00505 · Cited by 16
CID16020046, a GPR55 antagonist, attenuates sepsis‑induced acute kidney injury
Chen, R., Xu, H., Guo, Z., Zhāng, P., Chen, J., & Chen, Z. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12671 · Cited by 15
NLR family pyrin domain containing 3 (NLRP3) inflammasomes and peripheral neuropathic pain - Emphasis on microRNAs (miRNAs) as important regulators
Basu, P., Maier, C. G.-A., Averitt, D. L., & Basu, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175901 · Cited by 17
Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
Hu, Z., Qin, Z., Xie, J., Qu, Y., & Yin, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116271 · Cited by 15
The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis
Wróbel, A., Zapała, Ł., Zapała, P., Piecha, T., & Radziszewski, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173321 · Cited by 15
Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain
Tito, P. A. L., Bernardino, T. C. D. S., Bellozi, P. M. Q., da Silva, M. C. M., de Miranda, A. S., Vieira, É. L. M., Moreira, F. A., Palotás, A., de Oliveira, A. C. P., & Reis, H. J. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00301-8 · Cited by 15
Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels
Mlost, J., Kędziora, M., & Starowicz, K. (2021) · Pharmaceuticals · doi:10.3390/ph14100964 · Cited by 16
Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
Sokolaj, E. E., Assareh, N., Anderson, K. E., Aubrey, K. R., & Vaughan, C. W. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15964 · Cited by 16
Functional Selectivity of Coumarin Derivates Acting via GPR55 in Neuroinflammation
Apweiler, M., Streyczek, J., Saliba, S. W., Collado, J. A., Hurrle, T., Gräßle, S., Muñóz, E., Normann, C., Hellwig, S., Bräse, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020959 · Cited by 13
GPR55 contributes to neutrophil recruitment and mechanical pain induction after spinal cord compression in mice
Ono, T., Yamashita, T., Kano, R., Inoue, M., Okada, S., Kano, K., Koizumi, S., Iwabuchi, K., Hirabayashi, Y., Matsuo, I., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.008 · Cited by 13
Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature
Lefebvre, È., Tawil, N., & Yahia, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115858 · Cited by 12
Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
Alexander, S. P. H., Battey, J., Benson, H. E., Benya, R. V., Bonner, T. I., Davenport, A. P., Eguchi, S., Harmar, A. J., Holliday, N. D., Jensen, R. T., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f16/2019.5 · Cited by 12
Parkinson’s disease related alterations in cannabinoid transmission
Soti, M., Ranjbar, H., Kohlmeier, K. A., & Shabani, M. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.11.009 · Cited by 11
Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
Thapa, D., Warne, L. N., & Falasca, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914677 · Cited by 14
Genetic Models of the Endocannabinoid System
Monory, K., & Lutz, B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_5 · Cited by 12
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up-regulation of Serum IgE Levels in Immunized Mice
Newton, C. A., & Klein, T. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9361-4 · Cited by 12
Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases
Pistis, M., & Muntoni, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_11 · Cited by 12
Squaryl group modified phosphoglycolipid analogs as potential modulators of GPR55
Ding, F., Guy, A. T., Greimel, P., Hirabayashi, Y., Kamiguchi, H., & Ito, Y. (2018) · Chemical Communications · doi:10.1039/c8cc04467h · Cited by 12
Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy
Schoeder, C. T., Meyer, A. S., Mahardhika, A. B., Thimm, D., Blaschke, T., Funke, M., & Müller, C. E. (2019) · ACS Omega · doi:10.1021/acsomega.8b03695 · Cited by 12
GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
Zúñiga‐Romero, Á., Rivera-Plata, Q., Arrieta, J., Flores‐Murrieta, F. J., Rodríguez‐Silverio, J., Reyes-García, J. G., Huerta‐Cruz, J. C., Ramírez-Martínez, G., & Rocha-González, H. I. (2022) · Pharmaceuticals · doi:10.3390/ph15010067 · Cited by 11
Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain
Blanton, H. L., Armin, S., Muenster, S., Abood, M. E., & Benamar, K. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0006 · Cited by 11
Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12
Migraine: advances in treatment
Ashraf, U., & Goadsby, P. J. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.08.009 · Cited by 10
Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures
Brenneman, D. E., Kinney, W. A., McDonnell, M. E., Zhao, P., Abood, M. E., & Ward, S. J. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02038-2 · Cited by 10
Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies
Cunha, R. Z., Salamanca, G., Mille, F., Delprete, C., Franciosi, C., Piva, G., Gramenzi, A., & Chiocchetti, R. (2023) · Animals · doi:10.3390/ani13182833 · Cited by 11
Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
Mosca, M. G., Mangini, M., Cioffi, S., Barba, P., & Mariggiò, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00727-w · Cited by 10
GPR55: Physiological functions and therapeutic potential in depression
Miao, Y., Cheng, Y.-Y., & Guan, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117113 · Cited by 10
Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review
Gnasso, R., Corrado, B. M., Iommazzo, I., Migliore, F., Magliulo, G., Giardulli, B., & Ruosi, C. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02402-w · Cited by 8
Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database
Alexander, S. P. H., Battey, J., Benson, H. E., Benya, R. V., Bonner, T. I., Davenport, A. P., Singh, K. D., Eguchi, S., Harmar, A. J., Holliday, N. D., et al. (2020) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f16/2020.5 · Cited by 8
Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies
Vimal, D., D’Souza, L. C., Rai, V., Lal, S., Sharma, A., & Gupta, S. C. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220525124818 · Cited by 8
GPR55 activation alleviates cognitive dysfunction caused by neuropathic pain through modulation of microglia polarization and synaptic plasticity via the CaMKKβ/AMPK/SOCS3 signaling pathway
Zhao, F., Zhang, X., Liu, T., Sun, J., Li, X., Zhang, W., & Tian, X. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112070 · Cited by 7
Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives
Ben‐Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher‐Berkovich, S. (2026) · Biomolecules · doi:10.3390/biom16020225 · Cited by 7
Cannabinoid Signaling Through Non-CB1R/Non-CB2R Targets in Microglia
Rimmerman, N., Kozela, E., Levy, R., Vogel, Z., & Juknat, A. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_7 · Cited by 7
Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB 2 receptor agonists: identifying novel GPR55 inhibitors
Anavi‐Goffer, S., Irving, A. J., & Ross, R. A. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0142 · Cited by 7
Lysolipid Chain Length Switches Agonistic to Antagonistic G Protein-Coupled Receptor Modulation
Guy, A. T., Ding, F., Abe, J., Inoue, M., Hirabayashi, Y., Ito, Y., Kamiguchi, H., & Greimel, P. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00521 · Cited by 7
Cannabinoids and sepsis
Ladak, N., Beishon, L., Thompson, J. P., & Lambert, D. G. (2011) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2011.05.002 · Cited by 7
Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells
Kolbe, M. R., Hohmann, T., Hohmann, U., Maronde, E., Golbik, R. P., Prell, J., Illert, J., Strauß, C., & Dehghani, F. (2023) · Cells · doi:10.3390/cells12222646 · Cited by 6
Global deletion of G protein‐coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β‐cell turnover
Liu, B., Ruz‐Maldonado, I., & Persaud, S. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15816 · Cited by 5

Authors: Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., Chong, E., Mander, P. K., Green, P. J., Billinton, A., Fulleylove, M., Lancaster, H. C., Smith, J. C., Bailey, L. T., Wise, A., Brown, A. J., Richardson, J. C., & Chessell, I. P.
Affiliations: GlaxoSmithKline (United Kingdom) (GB)
King's College London (GB)
Corresponding author: Staton, Penny C.
ORCID: Morrison, Alastair D.
Smith, Jason C.
Brown, Andrew J.
Richardson, Jill C.
Venue: Pain
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-09-30
Volume: 139
Issue: 1
Pages: 225-236
ISSN: 0304-3959 (ISSN-L)
DOI: 10.1016/j.pain.2008.04.006
OpenAlex: W2015263236
Cited by: 270
References: 49
Citations by year: 2026: 3 · 2025: 12 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 21 · 2020: 18 · 2019: 10 · 2018: 9 · 2017: 20 · 2016: 15 · 2015: 16 · 2014: 10 · 2013: 14 · 2012: 23
FWCI: 13.09
Type: journal article
Language: en
Open access: closed
Locations: Pain (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords: GPR55, cannabinoid receptors, mechanical hyperalgesia, inflammatory pain, neuropathic pain, adjuvant-induced inflammation, cytokine expression, analgesia
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Female, Hyperalgesia, Inflammation, Ligation, Male, Mice, Inbred C57BL, Molecular Sequence Data, Neuralgia, Pain Measurement, Physical Stimulation, Mice, Knockout, Inflammation Mediators, Receptors, Cannabinoid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks